ValiRx plc (LON:VAL – Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 0.32 and traded as low as GBX 0.26. ValiRx shares last traded at GBX 0.26, with a volume of 4,788,559 shares changing hands.
ValiRx Trading Down 15.4%
The business has a 50 day moving average of GBX 0.29 and a two-hundred day moving average of GBX 0.32. The company has a current ratio of 5.50, a quick ratio of 1.27 and a debt-to-equity ratio of 0.27. The firm has a market cap of £1.52 million, a P/E ratio of -0.22 and a beta of 0.59.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Read More
- Five stocks we like better than ValiRx
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
